HKeybio to Partcipate in 2024 BIO

San Diego, California, 2024 – HKeybio, a leading biotechnology company specializing in autoimmune diseases, announces its participation at the upcoming 2024 BIO and Exhibition in the United States.

The 2024 BIO, one of the most prestigious events in the biotechnology industry, will be held from June 3rd to June 6th at the San Diego Convention Center in California. HKeybio is thrilled to present its groundbreaking research and innovative solutions at this highly-anticipated event.

HKeybio is renowned for its expertise in autoimmune disease animal model preclinical studies. The company offers a range of cutting-edge in vitro testing platforms, including molecular biochemistry detection, cell testing, and pathology analysis. With a commitment to advancing the field of autoimmune diseases.

"We are excited to showcase our latest advancements in autoimmune disease research at the 2024 BIO Conference," said Dr. Zhao, CEO of HKeybio. "Our team is looking forward to engaging with industry experts, sharing our insights, and exploring potential collaborations to further drive innovation in this critical area of biotechnology."

For more information about HKeybio and its presence at the 2024 BIO Conference, please visit: www.hkeybio.com

About HKeybio

HKeybio is a leading biotechnology company specializing in autoimmune diseases. With a focus on autoimmune disease animal model preclinical studies, HKeybio offers innovative in vitro testing platforms to support drug development and diagnostic research. Committed to advancing the field of autoimmune diseases.

Contact:

Email: marketing@hkeybio.com